ImMage Biotherapeutics

Founded in May 2015, ImMAGE Biotherapeutics Corp. is a seed-funded biotechnology company developing the first universal Immunotherapy to treat patients with an aggressive form of breast cancer called Triple NegativeBreast Cancer (TNBC).

Website : http://www.immagebio.com/

Call 2018

The 2018 call for applications for the Young Enterprise Initiative – Start in France is now open for Finnish, Italian, Taiwanese, and U.S. companies. The call will open soon for South African and South Korean companies.

Country Programs

@YeiAccelerator

Newsletter

Receive notifications about the YEi Start in France program (Call for applications, announcement of the laureates, YEi events, etc.)

Social Links